AhmadMohammad AminMasriMD

Adult Congenital Heart Disease

Physician

Dr. Masri is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
3181 SW Sam Jackson Park Rd
Portland, OR 97239
Phone+1 503-494-7400

Fax+1 503-494-4749

PubMed

Myocardial contraction fraction predicts outcomes in patients enrolled in the TOPCAT trial.
Bryton J Davis, Morris Kim, Yunwoo Burton, Miriam Elman, James Hodovan
International Journal of Cardiology. 2025-04-01
1 citations
Efficacy of Acoramidis on All-Cause Mortality and Cardiovascular Hospitalization in Transthyretin Amyloid Cardiomyopathy.
Daniel P Judge, Kevin M Alexander, Francesco Cappelli, Marianna Fontana, Pablo Garcia-Pavia
Journal of the American College of Cardiology. 2025-03-18
Safety and Efficacy of Mavacamten and Aficamten in Patients With Hypertrophic Cardiomyopathy.
Bryton J Davis, Hailey Volk, Olives Nguyen, Daniel Kamna, Hongya Chen
Journal of the American Heart Association. 2025-03-18

Lectures

The Role of Vasculature in Valvular Heart Disease
2019 ACC Scientific Session & Expo, New Orleans - 3/18/2019
Pulmonary Hypertension In Aortic and Mitral Valve Disease: Pathophysiology and Outcomes
2019 ACC Scientific Session & Expo, New Orleans - 3/18/2019
Case Presentation
2019 ACC Scientific Session & Expo, New Orleans - 3/17/2019

Cytokinetics Announces Launch of EARTH-HCM, a Public Health Education Tool for the Hypertrophic Cardiomyopathy CommunityMarch 20th, 2025
Cytokinetics Announces Five Presentations at the American College of Cardiology Annual Scientific Session & ExpoMarch 17th, 2025
Even on Tafamidis, ATTR-CM Patients Face High Mortality over TimeFebruary 13th, 2025
Join now to see all